Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för John Francis Cogan. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att John Francis Cogan har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:GILD / Gilead Sciences, Inc. | Director | 0 |
Director | 27 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av John Francis Cogan. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av John Francis Cogan som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 416 | 0 | −100,00 | |||
2020-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 416 | 54 860 | −4,22 | 81,75 | −197 508 | 4 484 805 | |
2020-05-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 416 | 57 276 | 4,40 | 19,63 | 47 426 | 1 124 328 |
2020-04-29 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 413 | 2 416 | −49,97 | |||
2020-04-29 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 413 | 54 860 | −4,21 | 79,90 | −192 799 | 4 383 314 | |
2020-04-29 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 413 | 57 273 | 4,40 | 19,63 | 47 367 | 1 124 269 |
2020-04-21 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 413 | 4 829 | −33,32 | |||
2020-04-21 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 413 | 54 860 | −4,21 | 83,00 | −200 279 | 4 553 380 | |
2020-04-21 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 413 | 57 273 | 4,40 | 19,63 | 47 367 | 1 124 269 |
2020-04-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 413 | 7 242 | −24,99 | |||
2020-04-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 413 | 54 860 | −4,21 | 75,90 | −183 147 | 4 163 874 | |
2020-04-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 413 | 57 273 | 4,40 | 19,63 | 47 367 | 1 124 269 |
2020-04-07 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 413 | 9 655 | −20,00 | |||
2020-04-07 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 413 | 54 860 | −4,21 | 79,52 | −191 882 | 4 362 467 | |
2020-04-07 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 413 | 57 273 | 4,40 | 19,63 | 47 367 | 1 124 269 |
2020-03-31 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 413 | 12 068 | −16,66 | |||
2020-03-31 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 413 | 54 860 | −4,21 | 75,35 | −181 820 | 4 133 701 | |
2020-03-31 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 413 | 57 273 | 4,40 | 19,63 | 47 367 | 1 124 269 |
2020-03-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 413 | 14 481 | −14,28 | |||
2020-03-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 413 | 54 860 | −4,21 | 75,27 | −181 627 | 4 129 312 | |
2020-03-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 413 | 57 273 | 4,40 | 19,63 | 47 367 | 1 124 269 |
2020-03-17 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 413 | 16 894 | −12,50 | |||
2020-03-17 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 413 | 54 860 | −4,21 | 67,26 | −162 298 | 3 689 884 | |
2020-03-17 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 413 | 57 273 | 4,40 | 19,63 | 47 367 | 1 124 269 |
2020-03-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 413 | 19 307 | −11,11 | |||
2020-03-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 413 | 54 860 | −4,21 | 77,97 | −188 142 | 4 277 434 | |
2020-03-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 413 | 57 273 | 4,40 | 19,63 | 47 367 | 1 124 269 |
2019-05-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 11 848 | 11 848 | |||||
2019-05-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
A - Award | 2 270 | 4 553 | 99,43 | ||||
2019-05-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 868 | 0 | −100,00 | |||
2019-05-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 868 | 54 860 | −4,97 | 64,89 | −186 116 | 3 560 079 | |
2019-05-02 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 868 | 57 728 | 5,23 | 22,02 | 63 139 | 1 270 882 |
2019-04-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 700 | 2 868 | −48,49 | |||
2019-04-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 700 | 54 860 | −4,69 | 62,61 | −169 054 | 3 434 927 | |
2019-04-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 700 | 57 560 | 4,92 | 22,02 | 59 440 | 1 267 183 |
2019-04-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 700 | 5 568 | −32,66 | |||
2019-04-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −100 | 54 860 | −0,18 | 64,66 | −6 466 | 3 547 248 | |
2019-04-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 600 | 54 960 | −4,52 | 64,21 | −166 958 | 3 529 229 | |
2019-04-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 700 | 57 560 | 4,92 | 22,02 | 59 440 | 1 267 183 |
2019-04-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 700 | 8 268 | −24,62 | |||
2019-04-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 700 | 54 860 | −4,69 | 67,23 | −181 521 | 3 688 238 | |
2019-04-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 700 | 57 560 | 4,92 | 22,02 | 59 440 | 1 267 183 |
2019-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 700 | 10 968 | −19,75 | |||
2019-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 700 | 54 860 | −4,69 | 66,74 | −180 198 | 3 661 356 | |
2019-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 700 | 57 560 | 4,92 | 22,02 | 59 440 | 1 267 183 |
2019-03-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 700 | 13 668 | −16,50 | |||
2019-03-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 700 | 54 860 | −4,69 | 64,14 | −173 178 | 3 518 720 | |
2019-03-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 700 | 57 560 | 4,92 | 22,02 | 59 440 | 1 267 183 |
2019-03-21 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 700 | 16 368 | −14,16 | |||
2019-03-21 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 700 | 54 860 | −4,69 | 65,07 | −175 689 | 3 569 740 | |
2019-03-21 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 2 700 | 57 560 | 4,92 | 22,02 | 59 440 | 1 267 183 |
2018-05-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
A - Award | 2 283 | 2 283 | |||||
2018-05-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 9 496 | 9 496 | |||||
2018-05-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
M - Exercise | −2 241 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 241 | 54 860 | 4,26 | ||||
2018-05-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 836 | 0 | −100,00 | |||
2018-05-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 836 | 52 619 | −9,98 | 65,09 | −379 885 | 3 425 150 | |
2018-05-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 5 836 | 58 455 | 11,09 | 26,62 | 155 325 | 1 555 780 |
2018-04-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 833 | 5 836 | −49,99 | |||
2018-04-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 833 | 52 619 | −9,98 | 73,91 | −431 117 | 3 889 070 | |
2018-04-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 5 833 | 58 452 | 11,09 | 26,62 | 155 245 | 1 555 700 |
2018-04-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 833 | 11 669 | −33,33 | |||
2018-04-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 333 | 52 619 | −9,20 | 73,77 | −393 435 | 3 881 893 | |
2018-04-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −500 | 57 952 | −0,86 | 73,39 | −36 696 | 4 253 155 | |
2018-04-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 5 833 | 58 452 | 11,09 | 26,62 | 155 245 | 1 555 700 |
2018-04-16 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 833 | 17 502 | −25,00 | |||
2018-04-16 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 833 | 52 619 | −9,98 | 75,56 | −440 741 | 3 975 892 | |
2018-04-16 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 5 833 | 58 452 | 11,09 | 26,62 | 155 245 | 1 555 700 |
2018-04-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 833 | 23 335 | −20,00 | |||
2018-04-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 833 | 52 619 | −9,98 | 74,47 | −434 384 | 3 918 537 | |
2018-04-09 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 5 833 | 58 452 | 11,09 | 26,62 | 155 245 | 1 555 700 |
2018-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 833 | 29 168 | −16,67 | |||
2018-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 833 | 52 619 | −9,98 | 74,93 | −437 067 | 3 942 742 | |
2018-04-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 5 833 | 58 452 | 11,09 | 26,62 | 155 245 | 1 555 700 |
2018-03-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 833 | 35 001 | −14,28 | |||
2018-03-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 833 | 52 619 | −9,98 | 75,02 | −437 588 | 3 947 441 | |
2018-03-26 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 5 833 | 58 452 | 11,09 | 26,62 | 155 245 | 1 555 700 |
2018-03-20 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 833 | 40 834 | −12,50 | |||
2018-03-20 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 833 | 52 619 | −9,98 | 80,09 | −467 138 | 4 214 008 | |
2018-03-20 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 5 833 | 58 452 | 11,09 | 26,62 | 155 245 | 1 555 700 |
2018-03-13 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 833 | 46 667 | −11,11 | |||
2018-03-13 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 833 | 52 619 | −9,98 | 80,93 | −472 065 | 4 258 456 | |
2018-03-13 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 5 833 | 58 452 | 11,09 | 26,62 | 155 245 | 1 555 700 |
2017-05-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
A - Award | 2 241 | 2 241 | |||||
2017-05-12 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 10 376 | 10 376 | |||||
2017-05-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 0 | −100,00 | |||
2017-05-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
M - Exercise | −1 787 | 0 | −100,00 | ||||
2017-05-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | X | −9 943 | 52 619 | −15,89 | 67,25 | −668 667 | 3 538 628 |
2017-05-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | X | 15 000 | 62 562 | 31,54 | 20,70 | 310 575 | 1 295 346 |
2017-05-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 1 787 | 47 562 | 3,90 | ||||
2016-05-13 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (Right to Buy) |
A - Award | 7 321 | 7 321 | |||||
2016-05-13 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
A - Award | 1 787 | 1 787 | |||||
2016-05-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Unit |
M - Exercise | −1 466 | 0 | −100,00 | ||||
2016-05-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 1 466 | 45 775 | 3,31 | ||||
2015-11-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −15 000 | 15 000 | −50,00 | |||
2015-11-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −15 000 | 44 309 | −25,29 | 105,95 | −1 589 190 | 4 694 361 | |
2015-11-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 15 000 | 59 309 | 33,85 | 20,70 | 310 575 | 1 227 993 | |
2015-10-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −15 000 | 30 000 | −33,33 | |||
2015-10-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −15 000 | 44 309 | −25,29 | 110,00 | −1 650 000 | 4 873 990 | |
2015-10-28 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 15 000 | 59 309 | 33,85 | 20,70 | 310 575 | 1 227 993 | |
2015-10-27 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −15 000 | 45 000 | −25,00 | |||
2015-10-27 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −15 000 | 44 309 | −25,29 | 110,00 | −1 650 000 | 4 873 990 | |
2015-10-27 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 15 000 | 59 309 | 33,85 | 20,70 | 310 575 | 1 227 993 | |
2015-09-17 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −15 000 | 60 000 | −20,00 | |||
2015-09-17 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −15 000 | 44 309 | −25,29 | 110,00 | −1 650 000 | 4 873 990 | |
2015-09-17 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 15 000 | 59 309 | 33,85 | 20,70 | 310 575 | 1 227 993 | |
2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −15 000 | 75 000 | −16,67 | |||
2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −15 000 | 44 309 | −25,29 | 120,00 | −1 800 000 | 5 317 080 | |
2015-08-04 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 15 000 | 59 309 | 33,85 | 20,70 | 310 575 | 1 227 993 | |
2015-06-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 90 000 | −14,29 | |||
2015-06-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −12 000 | 0 | −100,00 | |||
2015-06-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −27 000 | 44 309 | −37,86 | 120,13 | −3 243 421 | 5 322 694 | |
2015-06-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | −15 000 | 71 309 | −17,38 | 20,70 | −310 575 | 1 476 453 | |
2015-06-30 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 12 000 | 56 309 | 27,08 | 14,34 | 172 080 | 807 471 | |
2015-05-07 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Options (Right to Buy) |
A - Award | 5 167 | 5 167 | |||||
2015-05-07 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Units |
A - Award | 1 466 | 1 466 | |||||
2015-05-07 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Units |
M - Exercise | −1 904 | 0 | −100,00 | ||||
2015-05-07 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 1 904 | 44 309 | 4,49 | ||||
2014-12-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −26 000 | 0 | −100,00 | |||
2014-12-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −317 | 42 405 | −0,74 | 97,91 | −31 039 | 4 152 026 | |
2014-12-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −3 240 | 42 722 | −7,05 | 97,09 | −314 579 | 4 147 977 | |
2014-12-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −6 400 | 45 962 | −12,22 | 96,28 | −616 182 | 4 425 148 | |
2014-12-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 071 | 52 362 | −8,83 | 94,97 | −481 574 | 4 972 625 | |
2014-12-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 322 | 57 433 | −8,48 | 94,13 | −500 936 | 5 405 910 | |
2014-12-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 650 | 62 755 | −8,26 | 93,18 | −526 446 | 5 847 272 | |
2014-12-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 26 000 | 68 405 | 61,31 | 14,34 | 372 775 | 980 757 | |
2014-11-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −25 000 | 26 000 | −49,02 | |||
2014-11-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 500 | 42 405 | −5,57 | 102,51 | −256 275 | 4 346 937 | |
2014-11-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −7 515 | 44 905 | −14,34 | 101,55 | −763 172 | 4 560 246 | |
2014-11-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −14 985 | 52 420 | −22,23 | 100,86 | −1 511 323 | 5 286 856 | |
2014-11-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 25 000 | 67 405 | 58,96 | 14,34 | 358 438 | 966 419 | |
2014-10-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 51 000 | −22,73 | |||
2014-10-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 098 | 42 405 | −2,52 | 104,67 | −114 926 | 4 438 451 | |
2014-10-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −13 902 | 43 503 | −24,22 | 104,03 | −1 446 224 | 4 525 613 | |
2014-10-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 15 000 | 57 405 | 35,37 | 14,34 | 215 062 | 823 044 | |
2014-09-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 66 000 | −7,04 | |||
2014-09-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 801 | 42 405 | −4,07 | 107,48 | −193 571 | 4 557 668 | |
2014-09-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 303 | 44 206 | −2,86 | 106,60 | −138 894 | 4 712 170 | |
2014-09-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 896 | 45 509 | −4,00 | 105,76 | −200 522 | 4 813 059 | |
2014-09-24 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 5 000 | 47 405 | 11,79 | 14,34 | 71 688 | 679 669 | |
2014-08-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 71 000 | −6,58 | |||
2014-08-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 000 | 42 405 | −10,55 | 101,09 | −505 440 | 4 286 632 | |
2014-08-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 5 000 | 47 405 | 11,79 | 14,34 | 71 688 | 679 669 | |
2014-07-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 76 000 | −6,17 | |||
2014-07-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −1 196 | 42 405 | −2,74 | 90,16 | −107 827 | 3 823 091 | |
2014-07-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −3 804 | 43 601 | −8,02 | 89,52 | −340 515 | 3 902 948 | |
2014-07-23 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 5 000 | 47 405 | 11,79 | 14,34 | 71 688 | 679 669 | |
2014-06-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 81 000 | −5,81 | |||
2014-06-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −5 000 | 42 405 | −10,55 | 81,82 | −409 122 | 3 469 768 | |
2014-06-25 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 5 000 | 47 405 | 11,79 | 14,34 | 71 688 | 679 669 | |
2014-05-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Options (Right to Buy) |
A - Award | 4 868 | 4 868 | |||||
2014-05-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Units |
A - Award | 1 904 | 1 904 | |||||
2014-05-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Units |
M - Exercise | −2 863 | 0 | −100,00 | ||||
2014-05-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 2 863 | 42 405 | 7,24 | ||||
2014-04-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 86 000 | −5,49 | |||
2014-04-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 100 | 39 542 | −5,04 | 70,99 | −149 071 | 2 806 936 | |
2014-04-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −2 900 | 41 642 | −6,51 | 70,24 | −203 684 | 2 924 755 | |
2014-04-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 5 000 | 44 542 | 12,64 | 14,34 | 71 688 | 638 621 | |
2014-03-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −14 000 | 91 000 | −13,33 | |||
2014-03-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −200 | 39 542 | −0,50 | 77,07 | −15 414 | 3 047 502 | |
2014-03-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −13 800 | 39 742 | −25,77 | 76,43 | −1 054 687 | 3 037 346 | |
2014-03-18 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 14 000 | 53 542 | 35,41 | 14,34 | 200 725 | 767 658 | |
2013-08-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −17 000 | 0 | −100,00 | |||
2013-08-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −17 000 | 39 542 | −30,07 | 61,51 | −1 045 638 | 2 432 153 | |
2013-08-05 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 17 000 | 56 542 | 42,99 | 10,99 | 186 872 | 621 538 | |
2013-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −7 000 | 17 000 | −29,17 | |||
2013-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 24 000 | −29,41 | |||
2013-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −17 000 | 39 542 | −30,07 | 51,66 | −878 296 | 2 042 918 | |
2013-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 7 000 | 56 542 | 14,13 | 10,99 | 76 948 | 621 538 | |
2013-07-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 10 000 | 49 542 | 25,29 | 10,99 | 109 925 | 544 590 | |
2013-06-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | X | −110 000 | 34 000 | −76,39 | |||
2013-06-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
S - Sale | −110 000 | 39 542 | −73,56 | 52,15 | −5 736 885 | 2 062 254 | |
2013-06-11 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 110 000 | 149 542 | 278,19 | 10,99 | 1 209 175 | 1 643 840 | |
2013-05-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Units |
M - Exercise | −5 852 | 2 863 | −67,15 | ||||
2013-05-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 5 852 | 39 542 | 17,37 | ||||
2013-05-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Units |
A - Award | 2 863 | 8 715 | 48,92 | ||||
2013-05-10 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Option (Right to Buy) |
A - Award | 8 442 | 8 442 | |||||
2013-02-06 | 3 | NA |
Venture Lending & Leasing VII, Inc.
Common Shares |
27 | ||||||||
2012-05-15 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Units |
M - Exercise | −3 632 | 2 926 | −55,38 | ||||
2012-05-15 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 3 632 | 16 845 | 27,49 | ||||
2012-05-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Units |
A - Award | 2 926 | 6 558 | 80,56 | ||||
2012-05-14 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Options (right to buy) |
A - Award | 8 161 | 8 161 | |||||
2012-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Phantom Stock |
M - Exercise | −5 987 | 0 | −100,00 | ||||
2012-05-03 |
|
4 | GILD |
GILEAD SCIENCES INC
Common Stock |
M - Exercise | 5 987 | 13 213 | 82,85 | ||||
2009-05-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Restricted Stock Units |
A - Award | 3 406 | 3 406 | |||||
2009-05-08 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-Qualified Stock Options (right to buy) |
A - Award | 9 534 | 9 534 | |||||
2006-01-27 |
|
4 | GILD |
GILEAD SCIENCES INC
Non-qualified Stock Option (right to buy) |
A - Award | 3 000 | 3 000 |